Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Plasma Exchange in Refractory TTP
NCT00907751Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2010
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in thrombotic thrombocytopenic purpura (TTP), sponsored by Assistance publique - Hôpitaux de Paris. Started May 2010; status: completed.
02
Drugs
rituximab
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT00907751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907751.